The company is showcasing new development solutions and advanced digital technologies including its new OSD Express and Steriles Express solutions for drug development.
News|Articles|June 2, 2016
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-06-07-2016
- Volume 11
- Issue 6
ED-XRF Spectrometers Offer Rapid Elemental Analysis
SPECTRO XEPOS spectrometers handle rapid screening elemental analysis and support product quality control at-line for the manufacture of pharmaceuticals.
SPECTRO XEPOS spectrometers from SPECTRO Analytical Instruments feature energy dispersive X-ray fluorescence (ED-XRF) technology for multi-elemental analysis of major, minor, and trace element concentrations. The analyzers are designed to handle critical tasks including rapid screening elemental analysis and support product quality control at-line for a variety of applications including the manufacture of pharmaceuticals.
The spectrometers feature innovations in adaptive excitation plus tube and detector technologies to improve sensitivity by 10´ or more to boost precision, realize lower detection levels, and analyze of a range of elements. The TurboQuant II software analyzes unknown liquids, powders, or solid samples.
The spectrometers remain powered on between measurements to prevent on/off variations from affecting readings and ensure long-term stability.
Optional AMECARE M2M machine-to-machine support extends the analyzers’ self-diagnostic functions with proactive alerts, backed up by direct connection with a remote SPECTRO service PC.
Four versions are available, enabling users to prioritize their selection according to measurement speed, precision, or groups of targeted elements in specific matrices.
Source:
Articles in this issue
over 10 years ago
Slow Serialization Efforts May Delay Business Benefitsover 10 years ago
Scientific Approach Ensures Accurate Weighing Resultsover 10 years ago
Ensuring Biologic API Uniformityover 10 years ago
Biomanufacturing Outsourcing Budgets Grow, Slowlyover 10 years ago
Novasep Starts Kilogram-Scale Batch Production at US Facilityover 10 years ago
FUJIFILM Opens New Laboratory in North Carolinaover 10 years ago
Catalent Opens Korean Sales Officeover 10 years ago
Juniper Pharma Services Expands Topicals Capacityover 10 years ago
Raman Microscope Measures Uneven Surfacesover 10 years ago
Particle Analyzer Based on Light ScatteringRelated to this article
Ron Scarboro, Azurity Pharmaceuticals, explains when formulation robustness justifies added cost and which post-approval quality and supply metrics teams can track.
The winners of the CPHI Pharma Awards 2026 include a neurodegeneration platform, a track-and-trace packaging innovation, a enzymatic mRNA manufacturing technology, and a cell-free enzymatic biomanufacturing platform.
Richard Jaenisch explains why NAMs are compressing drug development faster than AI and what FDA's new nonclinical testing rule means for sponsors.
Shadow AI and vendor data retention put GMP records and trade secrets at risk. AI Pulse Check panelists outline what pharma AI policies require.
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.